Literature DB >> 16485889

The incidence of recurrent herpes simplex and herpes zoster infection during treatment with arsenic trioxide.

Keyvan Nouri1, Carlos A Ricotti, Navid Bouzari, Halland Chen, Eugene Ahn, Ardalan Bach.   

Abstract

We report the incidence of varicella zoster virus (VZV) and herpes simplex virus (HSV) infection in patients with multiple myeloma and colon cancer who were treated with arsenic trioxide for their disease. In this report, we discuss the effects of arsenic on immune system, and suggest arsenic compounds as a possible predisposing factor for viral reactivation in these patients.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16485889

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN： 1545-9616            Impact factor:   2.114


  7 in total

1.  Arsenic mediated disruption of promyelocytic leukemia protein nuclear bodies induces ganciclovir susceptibility in Epstein-Barr positive epithelial cells.

Authors:  Mark D Sides; Gregory J Block; Bin Shan; Kyle C Esteves; Zhen Lin; Erik K Flemington; Joseph A Lasky
Journal:  Virology       Date:  2011-05-24       Impact factor: 3.616

2.  Unfolded protein response (UPR) signaling regulates arsenic trioxide-mediated macrophage innate immune function disruption.

Authors:  Ritesh K Srivastava; Changzhao Li; Sandeep C Chaudhary; Mary E Ballestas; Craig A Elmets; David J Robbins; Sadis Matalon; Jessy S Deshane; Farrukh Afaq; David R Bickers; Mohammad Athar
Journal:  Toxicol Appl Pharmacol       Date:  2013-08-14       Impact factor: 4.219

3.  Activating transcription factor 4 underlies the pathogenesis of arsenic trioxide-mediated impairment of macrophage innate immune functions.

Authors:  Ritesh K Srivastava; Changzhao Li; Yong Wang; Zhiping Weng; Craig A Elmets; Kevin S Harrod; Jessy S Deshane; Mohammad Athar
Journal:  Toxicol Appl Pharmacol       Date:  2016-07-25       Impact factor: 4.219

Review 4.  The mechanistic basis of arsenicosis: pathogenesis of skin cancer.

Authors:  Katherine M Hunt; Ritesh K Srivastava; Craig A Elmets; Mohammad Athar
Journal:  Cancer Lett       Date:  2014-08-27       Impact factor: 8.679

5.  Arsenic trioxide stabilizes accumulations of adeno-associated virus virions at the perinuclear region, increasing transduction in vitro and in vivo.

Authors:  Angela M Mitchell; Chengwen Li; R Jude Samulski
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

6.  Entrapment of viral capsids in nuclear PML cages is an intrinsic antiviral host defense against varicella-zoster virus.

Authors:  Mike Reichelt; Li Wang; Marvin Sommer; John Perrino; Adel M Nour; Nandini Sen; Armin Baiker; Leigh Zerboni; Ann M Arvin
Journal:  PLoS Pathog       Date:  2011-02-03       Impact factor: 6.823

7.  Arsenic exposure and prevalence of the varicella zoster virus in the United States: NHANES (2003-2004 and 2009-2010).

Authors:  Andres Cardenas; Ellen Smit; E Andres Houseman; Nancy I Kerkvliet; Jeffrey W Bethel; Molly L Kile
Journal:  Environ Health Perspect       Date:  2015-01-30       Impact factor: 9.031
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.